Trump Promised Cheaper Drugs: Some Prices Fall, Others Jump
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
Visualize Index Level and price together to reveal trend strength and timing. This overview helps traders align momentum with price moves.
28,655 articlesAs of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
Investors are moving cash into ultra-short and short-term bond funds as yields edge above savings rates. A market hos...
A new Fed chair steps into a delicate mix of inflation pressures and a resilient job market. This guide breaks down c...
A high-profile mishap at a Denver show becomes a classroom for personal finance. Learn practical budgeting, impulse-c...
Major brokerages issued new research on top names like Airbnb, Broadcom, Chipotle, and NVIDIA as investors rotate str...
SpaceX aims for a $1.75 trillion IPO, triggering a fierce debate among analysts about whether growth, cash flow, and ...
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
When a top executive sells shares as a company commits billions to its hubs, it can spark questions. This article bre...
A U.S. strike on Iran triggered a rapid reevaluation of crypto mining and Bitcoin hashrate resilience, with analysts ...
Iran is creating a transit oversight agency to vet and tax vessels passing through the Strait of Hormuz, a developmen...
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...